This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Immunochemistry Products Market

Market Insights on Immunochemistry Products covering sales outlook, demand forecast & up-to-date key trends

Immunochemistry Products Market By Product Type (Immunochemistry analyzer, Chemiluminescence analyzers, Immuno fluorescence analyzers, Multiplexed Assay Systems, Centrifuges, Microscopes, Antibodies), End User (Hospitals and Clinics, Diagnostic laboratories), Application (Oncology, Cardiology, Endocrinology) & Region - Forecast 2022 - 2032

Immunochemistry Products Market Overview

The immunochemistry products market is anticipated to record a CAGR of 7.25% during the forecast period, up from US$ 2.08 Bn in 2021 to reach a valuation of US$ 4.5 Bn by 2032.

The immunochemistry products market is anticipated to show promising growth owing to its increase used to treat various illnesses and chronic diseases.

Attributes

Details

Immunochemistry Products Market Value (2021)

US$ 2.08 Bn

Immunochemistry Products Market Value (2032)

US$ 4.5 Bn

Immunochemistry Products Market CAGR (2022-2032)

7.25%

Sales of immunochemistry products are expected to rise as IHC (Immunochemistry) has grown in prominence in clinical diagnostics. As a result, the rising frequency of chronic illnesses is expected to boost demand for immunohistochemistry products, adding to immunochemistry market development.

Increasing number of patients with various diseases such as cardiovascular disorders and cancer is also projected to contribute to the growth of the immunochemistry products market share. Immunohistochemistry products are most widely utilized in cancer detection and treatment. Aside from that, the alarming increase in medical and healthcare spending, as well as the increasing focus on value-based healthcare solutions, are significantly boosting the sales of immunohistochemistry products and propelling the immunohistochemistry products market growth.

The report sheds light on the factors improving the sales of immunochemistry products, and, in turn, the opportunities for the market players. However, the immunochemistry products market also faces some challenges, which might limit the immunochemistry products market share from reaching its potential.

Some of the key immunochemistry products market trends promoting the demand for immunochemistry products include technological innovation and increased knowledge of novel diagnostic tools among medical professionals, as well as the availability of reimbursements for IHC tests, which have all been projected to favorably impact the growth of the global immunochemistry market.

Moreover, personalized medicine has shown to be incredibly beneficial for patients with non-small-cell lung cancer, and its usage is predicted to have a significant impact on sales of immunohistochemistry products. The creation of multiplex and mutation-specific immunochemistry tests is a significant advancement that is anticipated to boost the immunochemistry products market during 2022-2032.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Drivers of the Immunochemistry Products Market Share?

Cancer's rising incidence rate is anticipated to drive up the sales and demand for immunochemistry products throughout the forecasted period. As immunochemistry products are widely used to diagnose cancer and other disorders involving antigen-antibody reactions.

According to the National Institutes of Health (NIH), an estimated 1,735,350 new cancer cases were discovered in the United States in 2018, with 609,640 individuals dying from the illness, this factor had a great impact on the sales of immunochemistry products. Furthermore, the expanding geriatric population and the increasing number of diagnostic facilities are driving demand for Immunochemistry products and market development.

Biotechnology companies' increasing spending in research and development programmes and innovative strategies to increase the sales and demand for immunochemistry products are also positively impacting the immunochemistry products market growth.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which is the Leading Region in the Immunochemistry Products Market?

Depending on geographic regions, global immunochemistry market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.

North America followed by Europe dominates the global immunochemistry market due to the easing number of patients with cardiovascular disorder and cancers, growing aging population, developed healthcare infrastructure, and growing demand for immunochemistry products or immunoassay technologies in these regions. This region is also anticipated to record an increase in revenue generated by sales of immunochemistry products by key players.

Asia-Pacific is the fastest emerging market for global immunochemistry due to growing patient population with cardiac diseases, increasing awareness about advanced immunochemistry products available in the immunochemistry products market, developing healthcare infrastructure and rising government spending in healthcare industry in this region.

 How is the Competitive Landscape in the Immunochemistry Products Market?

Some of the key players in global immunochemistry market are F. Hoffmann-La Roche Ltd, Siemens Healthcare, Danaher Corporation, ImmunoChemistry Technologies, LLC, Beckman Coulter Inc., Ortho Clinical Diagnostics and Thermo Fisher Scientific Inc.

The report consists of key players contributing to the immunochemistry products market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analysis the competitive landscape and Immunochemistry Products market share acquired by players to strengthen their market position.

New Developments

  • Roche gained FDA clearance for the VENTANA MMR RxDx companion diagnostic test based on immunochemistry for solid tumours defective in the MMR pathway in August 2021. The test determines whether patients are candidates for GSK's anti-PD1 immunotherapy, JEMPERLI.
  • Agilent got a CE-IVD mark in Europe in August 2021 for their PD-L1 IHC 22C3 pharmDx test for identifying oesophageal cancer patients for therapy with KEYTRUDA.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope of Report

Report Attribute

Details

Growth rate

CAGR of 7.25% from 2022 to 2032

Base year for estimation

2021

Historical data

2015 - 2020

Forecast period

2022 - 2032

Quantitative units

Revenue in USD billion, volume in units, and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,

Segments covered

Product, application, end user, region

Regional scope

North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa

Key companies profiled

AGC Inc.; Cevital Group; Euroglas; Guardian Industries; Saint-Gobain; ?i?ecam Group; Vitro

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. 

Frequently Asked Questions

The immunochemistry products market is forecasted to register a CAGR of 7.25% during the forecast period.

Key players holding substantial Immunochemistry Products market share include F. Hoffmann-La Roche Ltd, Siemens Healthcare, Danaher Corporation, ImmunoChemistry Technologies, LLC, Beckman Coulter Inc., Ortho Clinical Diagnostics and Thermo Fisher Scientific Inc.

As per the analysis, the immunochemistry products market share is likely to be US$ 4.5 Bn by 2032.

Demand for immunochemistry products is likely to rise on the back of an increasing number of patients with various diseases such as cardiovascular disorders and cancer.

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Immunochemistry Products Market